Stay informed with the latest updates for the inheritable blood disorders community.

          Press Releases
          new NBDF
          The National Hemophilia Foundation is Now the National Bleeding…
          NBDF & Community
          Patient Assistance Programs
          HANDI Team Reminder – Learn More About Patient Assistance Programs
          Peer-Reviewed Journal Summaries
          Gynecologists Have Significant Part to Play in Shrinking Diagnostic Gaps
          Advocacy & Legislative
          Government Relations Update - April 2023
          Government Relations Update - July 2023
          Press Releases
          We look forward to seeing you at NHF's Bleeding Disorders Conference 2023.
          Embracing Change and Empowering Communities: 2023 Bleeding Disorders…
          Peer-Reviewed Journal Summaries
          Patient Safety in the Age of Gene Therapy a Central Focus of Review…
          NBDF & Community
          Paving the Road Ahead
          Medical
          Birth control pills
          FDA Approves First-Ever Nonprescription Oral Contraceptive
          NBDF & Community
          Peggy, a longtime community member shares her family's history of involvement and advocacy.
          A Longtime Legacy
          Advocacy & Legislative
          Government Relations Update - April 2023
          Government Relations Update - June 2023
          Industry
          Clinical Trial Lab Research
          New Trial Data Shows ALTUVIIIO™ Prophylaxis Effective in Children
          Industry
          FDA Approval
          Hemophilia A Gene Therapy Product Receives U.S. FDA Approval
          Medical
          Doctor and patient
          Patient-Clinician Partnerships the Theme of ASCO Presidential Address
          Industry
          First Hemophilia B Patient Dosed with Gene Therapy Product
          NBDF & Community
          Shaping the Future: Search Begins for New NHF CEO
          Shaping the Future: Search Begins for New NHF CEO